SIRT6 activatorsIntervention2 papers study itCWMHC, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.Funder: National Institute on AgingFunding1 grant since 2020National Institute on AgingUS$385kThe role of SIRT6 posttranslational modifications in aging and genome stability. Supplement: Testing SIRT6 activators as potential Alzheimer's disease therapy.National Institute on AgingUniversity of RochesterUS$385k2006–2023LatestAging and Disease·Jul 21SIRT6 in Vascular Diseases, from Bench to BedsideReviewSIRT6PaperGenes & Diseases·Feb 12Modulation of SIRT6 activity acts as an emerging therapeutic implication for pathological disorders in the skeletal systemReviewSIRT6Paper
Genes & Diseases·Feb 12Modulation of SIRT6 activity acts as an emerging therapeutic implication for pathological disorders in the skeletal systemReviewSIRT6Paper